-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
-
Summary
-
International Stem Cell CORP quarterly/annual Amortization of Intangible Assets history and growth rate from Q2 2013 to Q3 2024.
- International Stem Cell CORP Amortization of Intangible Assets for the quarter ending September 30, 2024 was $20K, unchanged year-over-year.
- International Stem Cell CORP Amortization of Intangible Assets for the twelve months ending September 30, 2024 was $83K, a 1.22% increase year-over-year.
- International Stem Cell CORP annual Amortization of Intangible Assets for 2023 was $82K, a 1.24% increase from 2022.
- International Stem Cell CORP annual Amortization of Intangible Assets for 2022 was $81K, a 11% decline from 2021.
- International Stem Cell CORP annual Amortization of Intangible Assets for 2021 was $91K, unchanged from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)